Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Status and Forecast 2020-2026

SKU ID :QYR-14553266 | Published Date: 20-Feb-2020 | No. of pages: 90
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.
North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.
Market Analysis and Insights: Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
In 2019, the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Scope and Market Size
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market is segmented into Paracetamol, Ibuprofen, Aspirin, Naproxen, Others, etc.
Segment by Application, the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, etc.
Regional and Country-level Analysis
The Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Analysis
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) business, the date to enter into the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) product introduction, recent developments, etc.
The major vendors include Novartis, Pfizer, Boehringer Ingelheim, Teva Pharmaceutical, Hospira, Lonza Group, Mylan, Aurobindo Pharma, Dr. Reddy's Laboratories, Actavis, Wuxi Apptec, Zhejiang NHU, etc.

This report focuses on the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study


Novartis
Pfizer
Boehringer Ingelheim
Teva Pharmaceutical
Hospira
Lonza Group
Mylan
Aurobindo Pharma
Dr. Reddy's Laboratories
Actavis
Wuxi Apptec
Zhejiang NHU

Market segment by Type, the product can be split into


Paracetamol
Ibuprofen
Aspirin
Naproxen
Others

Market segment by Application, split into


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers


North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:


To analyze global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) status, future forecast, growth opportunity, key market and key players.
To present the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
  • PRICE
  • $3900
    $7800
    Buy Now

Our Clients